Synthesis and biological evaluation of s‐, o‐ and se‐containing dispirooxindoles
A series of novel S-, O- and Se-containing dispirooxindole derivatives has been synthesized using 1,3-dipolar cycloaddition reaction of azomethine ylide generated from isatines and sarcosine at the double C=C bond of 5-indolidene-2-chalcogen-imidazolones (chalcogen was oxygen, sulfur or selenium). The cytotoxicity of these dispiro derivatives was evaluated in vitro using different tumor cell lines. Several molecules have demonstrated a considerable cytotoxicity against the panel and showed good selectivity towards colorectal carcinoma HCT116 p53+/+ over HCT116 p53−/− cells. In particular, good results have been obtained for LNCaP prostate cell line. The performed in silico study has revealed MDM2/p53 interaction as one of the possible targets for the synthesized molecules. However, in contrast to selectivity revealed during the cell-based evaluation and the results obtained in computational study, no significant p53 activation using a reporter construction in p53wt A549 cell line was observed in a relevant concentration range.
Citations by journals
1
2
|
|
International Journal of Molecular Sciences
|
International Journal of Molecular Sciences
2 publications, 28.57%
|
Molecules
|
Molecules
2 publications, 28.57%
|
New Journal of Chemistry
|
New Journal of Chemistry
1 publication, 14.29%
|
Advanced Synthesis and Catalysis
|
Advanced Synthesis and Catalysis
1 publication, 14.29%
|
Bioorganic Chemistry
|
Bioorganic Chemistry
1 publication, 14.29%
|
1
2
|
Citations by publishers
1
2
3
4
|
|
Multidisciplinary Digital Publishing Institute (MDPI)
|
Multidisciplinary Digital Publishing Institute (MDPI)
4 publications, 57.14%
|
Royal Society of Chemistry (RSC)
|
Royal Society of Chemistry (RSC)
1 publication, 14.29%
|
Wiley
|
Wiley
1 publication, 14.29%
|
Elsevier
|
Elsevier
1 publication, 14.29%
|
1
2
3
4
|
- We do not take into account publications that without a DOI.
- Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
- Statistics recalculated weekly.